NIOSH Pocket Guide to Chemical Hazards

Cadmium fume (as Cd) CAS 1306-19-0 (CdO)
CdO/Cd RTECS EV1930000 (CdO)
Synonyms & Trade Names
CdO: Cadmium monoxide, Cadmium oxide fume
Cd: Cadmium
DOT ID & Guide
Exposure
Limits
NIOSH REL*: Ca See Appendix A [*Note: The REL applies to all Cadmium compounds (as Cd).]
OSHA PEL*: [1910.1027] TWA 0.005 mg/m3 [*Note: The PEL applies to all Cadmium compounds (as Cd).]
IDLH Ca [9 mg/m3 (as Cd)] See: IDLH INDEX Conversion
Physical Description
Odorless, yellow-brown, finely divided particulate dispersed in air. [Note: See listing for Cadmium dust for properties of Cd.]
MW: 128.4
BP: Decomposes
MLT: 2599°F
Sol: Insoluble
VP: 0 mmHg (approx)
IP: NA

Sp.Gr: 8.15 (crystalline form)/6.95 (amorphous form)
Fl.P: NA
UEL: NA
LEL: NA

Noncombustible Solid
Incompatibilities & Reactivities
Not applicable
Measurement Methods
NIOSH 7048; OSHA ID121, ID125G, ID189, ID206
See: NMAM or OSHA Methods
Personal Protection & Sanitation
Skin: No recommendation
Eyes: No recommendation
Wash skin: Daily
Remove: No recommendation
Change: Daily

First Aid (See procedures)


Breathing: Respiratory support

Important additional information about respirator selection
Respirator Recommendations NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus
Exposure Routes inhalation
Symptoms Pulmonary edema, dyspnea (breathing difficulty), cough, chest tightness, substernal (occurring beneath the sternum) pain; headache; chills, muscle aches; nausea, vomiting, diarrhea; emphysema, proteinuria, anosmia (loss of the sense of smell), mild anemia; [potential occupational carcinogen]
Target Organs respiratory system, kidneys, blood

Cancer Site [prostatic & lung cancer]
See also: INTRODUCTION   See ICSC CARD: 0117   See MEDICAL TESTS: 0035

NIOSH Home |  NIOSH Search  | Site Index  | Topic List | Contact Us